Turning Point Brands Reports Strong Q4 Earnings, Beats Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 03 2026
0mins
Should l Buy TPB?
Source: Benzinga
Turning Point Brands Inc. experienced a significant decline of 19.20% in its stock price, crossing below the 20-day SMA, amid a broader market downturn with the Nasdaq-100 down 0.22% and the S&P 500 down 0.17%.
The company's recent Q4 earnings report revealed a non-GAAP EPS of $0.95, surpassing expectations by $0.07, and a revenue of $121.01 million, reflecting a 29.2% year-over-year increase. This strong performance indicates the company's ability to maintain profitability and market share despite the current market conditions. Analysts have expressed optimism about Turning Point Brands' future growth potential, anticipating continued benefits from market trends.
Despite the stock's decline, the robust earnings performance and positive analyst outlook suggest that the company remains well-positioned for future growth, potentially attracting investor interest in the long term.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TPB?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TPB
Wall Street analysts forecast TPB stock price to rise
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 108.510
Low
110.00
Averages
116.67
High
120.00
Current: 108.510
Low
110.00
Averages
116.67
High
120.00
About TPB
Turning Point Brands, Inc. is a manufacturer, marketer and distributor of branded consumer products. It sells a range of products to adult consumers, consisting of staple products under the brands Zig-Zag and Stoker’s. Its segments include Zig-Zag Products (Zig-Zag) and Stoker’s Products (Stoker’s). Zig-Zag principally markets and distributes rolling papers, tubes, and related products; finished cigars and make-your-own cigar wraps, and other accessories. It introduced Zig-Zag ‘Rillo-sized wraps, which are similar in size to cigarillos, a type of machine-made cigars. Stoker’s manufactures and markets moist snuff tobacco (MST) and contract for and market FRE, its modern oral product and contract for and market loose-leaf chewing tobacco products. Its products are available in approximately 200,000 in the United States retail locations which, with the addition of retail stores in Canada, brings its total North American retail presence to an estimated 220,000 points of distribution.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cannell Capital Sells Turning Point Brands Shares in Q4
- Share Sale Details: Cannell Capital sold 128,224 shares of Turning Point Brands in Q4 2025, with an estimated transaction value of $12.54 million based on the average stock price for the quarter, indicating a strategic move to realize gains.
- Decline in Position Value: The fund's quarter-end position value decreased by $12.18 million, reflecting both the impact of share sales and fluctuations in stock price, which highlights the volatility in the market.
- Company Performance Overview: Turning Point Brands reported approximately $463 million in net sales for 2025, a 28% increase, with net income of $58 million and adjusted EBITDA around $119.5 million, demonstrating strong earnings power from its core brands.
- Market Performance Analysis: Although Cannell Capital trimmed its stake to less than 3% of assets, Turning Point Brands' stock has risen 53% over the past year, indicating robust demand and margin expansion across convenience channels.
See More
Cannell Capital Sells Shares of Turning Point Brands
- Share Sale Overview: Cannell Capital reported the sale of 128,224 shares of Turning Point Brands in its February 17, 2026 SEC filing, with an estimated transaction value of $12.54 million, reflecting the company's strong performance in Q4 2025.
- Asset Management Impact: Following the sale, Turning Point Brands now constitutes 2.73% of Cannell Capital's 13F reportable AUM, while the fund's quarter-end position dropped by $12.18 million, indicating the impact of market fluctuations on its portfolio.
- Company Performance Highlights: Turning Point Brands achieved net sales of approximately $463 million in 2025, a 28% increase year-over-year, with net income of $58 million, showcasing strong cash flow in the rolling papers and alternative tobacco products sector.
- Investor Outlook Analysis: This share sale may represent Cannell Capital's strategy to lock in gains after a strong performance, and while reducing the position to below 3% does not imply abandonment of the long-term view, future growth will depend on brand durability and pricing power.
See More
Turning Point Brands Reports 29% Revenue Growth in Q4
- Significant Revenue Growth: Turning Point Brands reported a 29% increase in revenue for Q4, reaching $121 million, demonstrating strong market performance, particularly in the rapidly expanding Modern Oral product segment.
- Adjusted EBITDA Improvement: The company’s adjusted EBITDA rose by 14% to $30 million, reflecting enhanced operational efficiency and profitability, further solidifying its position in a competitive market.
- Surge in Modern Oral Sales: Net sales for Modern Oral products skyrocketed by 266% year over year to $41.3 million, indicating successful positioning in this emerging market, which is expected to drive sustained growth moving forward.
- Market Investments and Challenges: Despite a 13% decline in Zig-Zag sales, the company is actively investing in sales and marketing to counter potential tax increases and tariff impacts, thereby maintaining its competitive edge in the industry.
See More
Turning Point Brands Reports Q4 2025 Results, Shares Decline
- Earnings Decline: Turning Point Brands reported its Q4 2025 results, with CEO Graham Purdy indicating a potential for double-digit market share in the modern oral category, yet shares fell over 16.5%, reflecting market concerns about performance.
- Stable Cash Flows: Legacy brands like FRE and ALP continue to generate durable cash flows, providing financial stability for the company despite increasing competition in the modern oral products market.
- Dividend Increase: Last month, Turning Point raised its quarterly dividend from 7 cents to 8 cents per share, payable on April 10 to shareholders of record as of March 20, aiming to bolster investor confidence and attract more investment.
- Future Outlook: The company projects FY26 net revenue for the Modern Oral segment between $180 million and $190 million, with first-quarter adjusted EBITDA expected to be between $24 million and $27 million, indicating confidence in future growth despite market challenges.
See More
Turning Point Brands Reports Q4 Earnings Decline Amid Strategic Shift
- Significant Sales Growth: Turning Point Brands reported a 29% increase in sales for Q4, with adjusted earnings per share dipping 3%, yet both metrics surpassed Wall Street expectations, indicating the company's competitive strength during its transition.
- Profitability Challenges: Management anticipates a 15% sequential decline in adjusted EBITDA, reflecting the challenges faced during the shift from traditional smoking accessories to white nicotine pouches, leading the market to adopt a wait-and-see approach.
- Surge in Nicotine Pouch Sales: Sales of nicotine pouches soared by 266% in Q4, accounting for 34% of total sales, up from 12% last year, highlighting the company's successful pivot to new product lines that are expected to become major revenue sources.
- Rising Costs Impacting Profitability: Despite sales growth, SG&A expenses rose by 38% in Q4, slightly outpacing revenue growth and causing a decline in profitability, indicating the pressure from investments in marketing and new production capabilities.
See More
Turning Point Reports 29% Sales Growth in Q4 Amid Earnings Dip
- Significant Sales Growth: Turning Point's sales increased by 29% in Q4, while adjusted earnings per share dipped by 3%, surpassing Wall Street expectations and indicating strong market demand during the company's transition.
- Surge in Nicotine Pouch Sales: Nicotine pouch sales soared by 266% in Q4, accounting for 34% of total sales, up from just 12% last year, demonstrating the company's successful expansion of its distribution network and potential as a primary revenue source.
- Rising Costs Impact Profitability: Despite sales growth, SG&A expenses rose by 38% in Q4, slightly outpacing revenue growth and leading to a decline in profitability, reflecting the cost pressures faced during the transition.
- Optimistic Market Outlook: Although shares fell by 20%, the market remains cautiously optimistic about Turning Point's future, with the nicotine pouch market projected to grow by at least 20% over the next five years, as the company actively adjusts its strategy to align with this trend.
See More
Cannell Capital Sells Turning Point Brands Shares in Q4
- Share Sale Details: Cannell Capital sold 128,224 shares of Turning Point Brands in Q4 2025, with an estimated transaction value of $12.54 million based on the average stock price for the quarter, indicating a strategic move to realize gains.
- Decline in Position Value: The fund's quarter-end position value decreased by $12.18 million, reflecting both the impact of share sales and fluctuations in stock price, which highlights the volatility in the market.
- Company Performance Overview: Turning Point Brands reported approximately $463 million in net sales for 2025, a 28% increase, with net income of $58 million and adjusted EBITDA around $119.5 million, demonstrating strong earnings power from its core brands.
- Market Performance Analysis: Although Cannell Capital trimmed its stake to less than 3% of assets, Turning Point Brands' stock has risen 53% over the past year, indicating robust demand and margin expansion across convenience channels.
See More
Cannell Capital Sells Shares of Turning Point Brands
- Share Sale Overview: Cannell Capital reported the sale of 128,224 shares of Turning Point Brands in its February 17, 2026 SEC filing, with an estimated transaction value of $12.54 million, reflecting the company's strong performance in Q4 2025.
- Asset Management Impact: Following the sale, Turning Point Brands now constitutes 2.73% of Cannell Capital's 13F reportable AUM, while the fund's quarter-end position dropped by $12.18 million, indicating the impact of market fluctuations on its portfolio.
- Company Performance Highlights: Turning Point Brands achieved net sales of approximately $463 million in 2025, a 28% increase year-over-year, with net income of $58 million, showcasing strong cash flow in the rolling papers and alternative tobacco products sector.
- Investor Outlook Analysis: This share sale may represent Cannell Capital's strategy to lock in gains after a strong performance, and while reducing the position to below 3% does not imply abandonment of the long-term view, future growth will depend on brand durability and pricing power.
See More
Turning Point Brands Reports 29% Revenue Growth in Q4
- Significant Revenue Growth: Turning Point Brands reported a 29% increase in revenue for Q4, reaching $121 million, demonstrating strong market performance, particularly in the rapidly expanding Modern Oral product segment.
- Adjusted EBITDA Improvement: The company’s adjusted EBITDA rose by 14% to $30 million, reflecting enhanced operational efficiency and profitability, further solidifying its position in a competitive market.
- Surge in Modern Oral Sales: Net sales for Modern Oral products skyrocketed by 266% year over year to $41.3 million, indicating successful positioning in this emerging market, which is expected to drive sustained growth moving forward.
- Market Investments and Challenges: Despite a 13% decline in Zig-Zag sales, the company is actively investing in sales and marketing to counter potential tax increases and tariff impacts, thereby maintaining its competitive edge in the industry.
See More
Turning Point Brands Reports Q4 2025 Results, Shares Decline
- Earnings Decline: Turning Point Brands reported its Q4 2025 results, with CEO Graham Purdy indicating a potential for double-digit market share in the modern oral category, yet shares fell over 16.5%, reflecting market concerns about performance.
- Stable Cash Flows: Legacy brands like FRE and ALP continue to generate durable cash flows, providing financial stability for the company despite increasing competition in the modern oral products market.
- Dividend Increase: Last month, Turning Point raised its quarterly dividend from 7 cents to 8 cents per share, payable on April 10 to shareholders of record as of March 20, aiming to bolster investor confidence and attract more investment.
- Future Outlook: The company projects FY26 net revenue for the Modern Oral segment between $180 million and $190 million, with first-quarter adjusted EBITDA expected to be between $24 million and $27 million, indicating confidence in future growth despite market challenges.
See More
Turning Point Brands Reports Q4 Earnings Decline Amid Strategic Shift
- Significant Sales Growth: Turning Point Brands reported a 29% increase in sales for Q4, with adjusted earnings per share dipping 3%, yet both metrics surpassed Wall Street expectations, indicating the company's competitive strength during its transition.
- Profitability Challenges: Management anticipates a 15% sequential decline in adjusted EBITDA, reflecting the challenges faced during the shift from traditional smoking accessories to white nicotine pouches, leading the market to adopt a wait-and-see approach.
- Surge in Nicotine Pouch Sales: Sales of nicotine pouches soared by 266% in Q4, accounting for 34% of total sales, up from 12% last year, highlighting the company's successful pivot to new product lines that are expected to become major revenue sources.
- Rising Costs Impacting Profitability: Despite sales growth, SG&A expenses rose by 38% in Q4, slightly outpacing revenue growth and causing a decline in profitability, indicating the pressure from investments in marketing and new production capabilities.
See More
Turning Point Reports 29% Sales Growth in Q4 Amid Earnings Dip
- Significant Sales Growth: Turning Point's sales increased by 29% in Q4, while adjusted earnings per share dipped by 3%, surpassing Wall Street expectations and indicating strong market demand during the company's transition.
- Surge in Nicotine Pouch Sales: Nicotine pouch sales soared by 266% in Q4, accounting for 34% of total sales, up from just 12% last year, demonstrating the company's successful expansion of its distribution network and potential as a primary revenue source.
- Rising Costs Impact Profitability: Despite sales growth, SG&A expenses rose by 38% in Q4, slightly outpacing revenue growth and leading to a decline in profitability, reflecting the cost pressures faced during the transition.
- Optimistic Market Outlook: Although shares fell by 20%, the market remains cautiously optimistic about Turning Point's future, with the nicotine pouch market projected to grow by at least 20% over the next five years, as the company actively adjusts its strategy to align with this trend.
See More
